Related Experiment Video
Updated: Jul 17, 2026

Rapid Analysis and Exploration of Fluorescence Microscopy Images
Published on: March 19, 2014
Feature-map vectors: a new class of informative descriptors for computational drug discovery
Gregory A Landrum1, Julie E Penzotti, Santosh Putta
1Novartis Institutes For BioMedical Research, CH-4002, Basel, Switzerland. gregory.landrum@novartis.com
Abstract:
In order to develop robust machine-learning or statistical models for predicting biological activity, descriptors that capture the essence of the protein-ligand interaction are required. In the absence of structural information from X-ray or NMR experiments, deriving informative descriptors can be difficult. We have developed feature-map vectors (FMVs), a new class of descriptors based on chemical features, to address this challenge. FMVs, which are derived from the conformational models of a few actives, are low dimensional, problem specific, and highly interpretable. By using shape-based alignments and scoring with chemical features, FMVs can combine information about a molecule's shape and the pharmacophores it can match. In five validation studies, bag classifiers built using FMVs have shown high enrichments for identifying actives for five diverse targets: CDK2, 5-HT(3), DHFR, thrombin, and ACE. The interpretability of these descriptors has been demonstrated for CDK2 and 5-HT(3), where the method automatically discovers the standard literature pharmacophore.
Related Concept Videos
Drug Discovery: Overview
Pharmacogenomics: Identification of New Drug Targets
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Drug Classes and Categories
Drug Nomenclature
